1Kojuri J, Vosonghi AR, Akrami M. Effects of anethum graveolens and garlic an lipid profite in hyperlipidemic patients [ J ]. Lipids Health Dis,2007,6:5.
3Sanerjee KB, Maulik SK. Effect of garlic on cardiovascular disorders : a review[ J]. Nutr J ,2002,1:4.
4Augusti KT, Chackery J, Jacob J, et al. Beneficial effects of a polar fraction of garlic ( Allium sativum linn) oil in rats fed with two different high diets [ J ]. Indian J Exp Biol, 2005,43(1) :76.
5Liu L, Yeh YY. Water-soluble organosulphur compounds of garlic inhibit fatty acid and triglyceride synthesis in cultured rat hepatocytes [ J ]. Lipids ,2001,36 ( 4 ) : 395.
6Ambati S,Yang JY, Rayalam S,et al. Ajoene exerts potent effects in 3T3-L1 adipocytes by inhibiting adipogenesis and inducing apoptosis [ J]. Phytother Res ,2009,23 ( 4 ) :513.
7Jialal I, Devaraj S. Low-density lipoprotein oxidation,an- tioxidants,and atherosclerosis: a clinical biochemistry perspective [ J ]. Clin Chem, 1996,42 ( 4 ) :498.
二级参考文献10
1Bilgen D, Sonmez H, Ekmekci H, et al. The relationship of TFPI, Lp (a), and oxidized LDL antibody levels in patients with coronary artery disease E J3- Clin Biochem, 2005, 38(1): 92-96.
2Karvonen J, Paivansalo M. Immunoglobulin M type of autoantibodies to oxidized low density lipoprotein has an inverse relation to carotid artery atherosclerosis[J].Circulation, 2003, 108 (17): 2107-2112.
3Diehm C, Kareem S, Lawall H. Epidemiology of peripheral arterial disease [J]. Vasa, 2004, 3 (4): 183-189.
4Olkkonen VM, Lehto M. Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis[J].Ann Med, 2004, B6 (8):562-572.
5Bareleet GR. Phosphorus assay in column chromatography[J].J Biol Chem, 1959, 234: 466-468.
6Golden SH, Maguire A, Ding J, et al. Endogenouspos tmenopausal hormones and carotid atherosclerosis: a casecontrol study of the atherosclerosis risk in communities cohort[J].Am J Epidemiol, 2002. 155 (5):437-445.
7Traupe T, Ortmann J, Munter K, et al. Endothelial therapy of atherosclerosis and its risk factors [J ]. Curr Vasc Pharmacol, 2003, 1 (2): 111-121.
8Falk E. Pathogenesis of atherosclerosis[J]. J Am Coll Cardiol, 2006, 47 (8 Suppl): C7-12.
9Kougias P, Chai H, Lin PH, et al. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis[J].Med Sci Monit, 2006, 12 (1): RA5-16.
